USA— Researchers at the University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based method for identifying high-affinity antibody therapeutics. The approach was used to identify…
Read MoreTag: Artificial Intelligence
Bayer bolsters radiology division with Blackford AI acquisition
GERMANY — Bayer has purchased Blackford Analysis and its Blackford Platform, an all-in-one software solution for radiology, expanding its radiology application offerings. The financial terms of the deal, which is…
Read MoreSaudi Arabia to administer COVID-19 booster shots, signs medical technology deal
SAUDI ARABI – The Saudi Ministry of Health (MOH) has authorized updated COVID-19 boosters for adults to broaden protection ahead of this year’s Muslim Hajj (pilgrimage) season in June. It…
Read MoreJ&J & SciBase collaborate to develop skin-screening AI to predict eczema in newborns
USA — SciBase, a developer of augmented intelligence-based solutions for skin disorders has signed a collaboration agreement with Johnson & Johnson Consumer to develop an AI-based screening tool to predict…
Read MoreInsilico Medicine pens US$1.2B research collaboration with Sanofi
HONG KONG —Insilico Medicine, a clinical-stage AI-driven drug discovery company, has signed a US$1.2 billion multi-year, multi-target strategic research collaboration with Sanofi. Sanofi is a global pharmaceutical company headquartered in…
Read MoreFDA approves Philips artificial intelligence-powered MRI scan for head and neck cancers
USA — The U.S. Food and Drug Administration (FDA) has granted Philips 510(k) clearance for its AI-powered MRI platform tailored to the treatment of head and neck cancers. The software…
Read MoreBioMed X, Sanofi partner on AI-based drug development for chronic immune-mediated diseases
GERMANY — BioMed X, a German independent research institute has formed a research collaboration with Sanofi to use artificial intelligence (AI) in drug development. The preliminary model will focus on…
Read MoreGSK expands AI partnership with Tempus, pays US$70M to access patient data library
USA — GSK, a British multinational pharmaceutical and biotech company has entered into a three-year partnership with Tempus to expand its access to its AI-powered data library, including de-identified patient…
Read MoreRoche Pharma sets up its second data analytics center in India
INDIA — Swiss multinational biotech giant Roche Pharma has set up a state-of-the-art Global Analytics and Technology Centre of Excellence (GATE) in Hyderabad, making it the company’s second data analytics…
Read MoreOptellum raises US$14M in funding round to commercialize lung cancer diagnostic platform
UNITED KINGDOM – Optellum Ltd. UK-based medtech company that provides an AI platform to diagnose and treat early-stage lung cancer has raised US$14 million in a series A funding round…
Read More